197 related articles for article (PubMed ID: 24929433)
21. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of malignant hemopathies recorded in hospitals in Cameroon.
Moueleu Ngalagou PT; Ngouadjeu Dongho Tsakeu E; Ngo Sack F; Eboumbou Moukoko EC; Konn Jolly Y; Luma H
Med Sante Trop; 2018 Feb; 28(1):61-66. PubMed ID: 29616647
[TBL] [Abstract][Full Text] [Related]
23. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
[TBL] [Abstract][Full Text] [Related]
24. Risk of hematological malignancy in blood donors: A nationwide cohort study.
Zhao J; Dahlén T; Brynolf A; Edgren G
Transfusion; 2020 Nov; 60(11):2591-2596. PubMed ID: 32818321
[TBL] [Abstract][Full Text] [Related]
25. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
Pulte D; Gondos A; Brenner H
J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
[TBL] [Abstract][Full Text] [Related]
26. Age and sex distributions of hematological malignancies in the U.K.
McNally RJ; Rowland D; Roman E; Cartwright RA
Hematol Oncol; 1997 Nov; 15(4):173-89. PubMed ID: 9722889
[TBL] [Abstract][Full Text] [Related]
27. Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program.
Pagano L; Girmenia C; Mele L; Ricci P; Tosti ME; Nosari A; Buelli M; Picardi M; Allione B; Corvatta L; D'Antonio D; Montillo M; Melillo L; Chierichini A; Cenacchi A; Tonso A; Cudillo L; Candoni A; Savignano C; Bonini A; Martino P; Del Favero A; ;
Haematologica; 2001 Aug; 86(8):862-70. PubMed ID: 11522544
[TBL] [Abstract][Full Text] [Related]
28. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.
Trejo O; Ramos-Casals M; López-Guillermo A; García-Carrasco M; Yagüe J; Cervera R; Font J; Ingelmo M
Semin Arthritis Rheum; 2003 Aug; 33(1):19-28. PubMed ID: 12920693
[TBL] [Abstract][Full Text] [Related]
29. [Hematological Neoplasms Secondary to Malignant Solid Tumors with Radiotherapy and Chemotherapy: a Clinical and Prognostic Analysis].
Ren J; Lu LN; Wang G; Zhang RJ; Ma YP; Yang LH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):383-388. PubMed ID: 37096509
[TBL] [Abstract][Full Text] [Related]
30. Non-AIDS-defining hematological malignancies in HIV-infected patients: an epidemiological study in Japan.
Hagiwara S; Yotsumoto M; Odawara T; Ajisawa A; Uehira T; Nagai H; Tanuma J; Okada S
AIDS; 2013 Jan; 27(2):279-83. PubMed ID: 23014520
[TBL] [Abstract][Full Text] [Related]
31. Hematological malignancies in East Africa-Which cancers to expect and how to provide services.
Leak SA; Mmbaga LG; Mkwizu EW; Mapendo PJ; Henke O
PLoS One; 2020; 15(5):e0232848. PubMed ID: 32374771
[TBL] [Abstract][Full Text] [Related]
32. The incidence of hematological neoplasms morbidity on radiation-contaminated territories in Cherkasy region.
Paramonov VV
Probl Radiac Med Radiobiol; 2017 Dec; 22():428-449. PubMed ID: 29286525
[TBL] [Abstract][Full Text] [Related]
33. Hematological malignancies in the Northwest Ethiopia.
Enawgaw B; Aynalem M; Melku M; Asrie F; Abebe M; Yalew A; Bekele T; Mesfin N; Ayalew M; Shiferaw E
PLoS One; 2021; 16(12):e0260639. PubMed ID: 34852010
[TBL] [Abstract][Full Text] [Related]
34. Spectrum of haematologic malignancies and survival outcomes of adult lymphomas in Maiduguri, north eastern Nigeria--a fourteen year review.
Kagu MB; Ahmed SG; Bukar AA; Mohammed AA; Mayun AA; Musa AB
Afr J Med Med Sci; 2013 Mar; 42(1):5-14. PubMed ID: 23909089
[TBL] [Abstract][Full Text] [Related]
35. Ageing, exposure to pollution, and interactions between climate change and local seasons as oxidant conditions predicting incident hematologic malignancy at KINSHASA University clinics, Democratic Republic of CONGO (DRC).
Nkanga MSN; Longo-Mbenza B; Adeniyi OV; Ngwidiwo JB; Katawandja AL; Kazadi PRB; Nzonzila AN
BMC Cancer; 2017 Aug; 17(1):559. PubMed ID: 28835214
[TBL] [Abstract][Full Text] [Related]
36. Frequency of hematologic malignancies in the population of Arica, Chile.
Pérez GB; Calaf GM; Villalba MTM; Prieto KS; Burgos FC
Oncol Lett; 2019 Nov; 18(5):5637-5643. PubMed ID: 31612068
[TBL] [Abstract][Full Text] [Related]
37. Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006-2010): based on registry data from the Japanese Society of Pediatric Hematology.
Horibe K; Saito AM; Takimoto T; Tsuchida M; Manabe A; Shima M; Ohara A; Mizutani S
Int J Hematol; 2013 Jul; 98(1):74-88. PubMed ID: 23702913
[TBL] [Abstract][Full Text] [Related]
38. [The age and sex frequencies of patients with leukemia seen in two reference centers in the metropolitan area of Mexico City].
Santoyo-Sánchez A; Ramos-Peñafiel CO; Saavedra-González A; González-Almanza L; Martínez-Tovar A; Olarte-Carrillo I; Collazo-Jaloma J
Gac Med Mex; 2016; 152(2):208-12. PubMed ID: 27160620
[TBL] [Abstract][Full Text] [Related]
39. [Clinical features of acute leukemia and its relationship to the season of the year].
Santoyo-Sánchez A; Ramos-Peñafiel C; Palmeros-Morgado G; Mendoza-García E; Olarte-Carrillo I; Martínez-Tovar A; Collazo-Jaloma J
Rev Med Inst Mex Seguro Soc; 2014; 52(2):176-81. PubMed ID: 24758856
[TBL] [Abstract][Full Text] [Related]
40. Palliative Care for Patients With Hematologic Malignancies in a Low-Middle Income Country: Prevalence of Symptoms and the Need for Improving Quality of Attention at the End of Life.
Jaime-Pérez JC; Turrubiates-Hernández GA; Nava-Obregón T; Coronado-Hernández B; Gutiérrez-Aguirre H; Cantú-Rodríguez OG; Herrera-Garza JL; Gómez-Almaguer D
Am J Hosp Palliat Care; 2020 Aug; 37(8):600-605. PubMed ID: 31714147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
